Sandbox:khurram: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 53: Line 53:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Factor V Leiden
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Factor V Leiden mutation
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 19:41, 20 August 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Platelet count Bleeding time PT PTT Peripheral blood smear Imaging 1 Imaging 2 Imaging 3
Antithrombin deficiency
Factor V Leiden mutation
Protein C deficiency
Protein S deficiency
Prothrombin gene mutation
von Willebrand disease Ristocetin cofactor assay
DIC

References

Template:WH Template:WS